ATARA BIOTHERAPEUTICS, INC. Interest Payable, Current
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Interest Payable, Current of $763.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2023-11-01
- 2023-09-30: Interest Payable, Current $763.00K.
- 2023-06-30: Interest Payable, Current $641.00K.
- 2023-03-31: Interest Payable, Current $349.00K.
- 2022-12-31: Interest Payable, Current $0.00.
| Period end | Interest Payable, Current |
|---|---|
| 2023-09-30 | $763.00K 10-Q · filed 2023-11-01 |
| 2023-06-30 | $641.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $349.00K 10-Q · filed 2023-05-08 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |